Ekso Bionics Holdings Inc has a consensus price target of $10, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 30, 2024, March 5, 2024, and January 22, 2024. With an average price target of $9.75 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 650.00% upside for Ekso Bionics Holdings Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 669.23% | HC Wainwright & Co. | Swayampakula Ramakanth | $9.25 → $10 | Maintains | Buy | Get Alert |
03/05/2024 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 611.54% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $9.25 | Maintains | Buy | Get Alert |
01/22/2024 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 669.23% | HC Wainwright & Co. | Swayampakula Ramakanth | $9 → $10 | Maintains | Buy | Get Alert |
04/28/2023 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 592.31% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
03/30/2023 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 592.31% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
07/29/2022 | EKSO | Buy Now | Ekso Bionics Holdings | $1.30 | 592.31% | HC Wainwright & Co. | Swayampakula Ramakanth | $11 → $9 | Maintains | Buy | Get Alert |
The latest price target for Ekso Bionics Holdings (NASDAQ: EKSO) was reported by HC Wainwright & Co. on April 30, 2024. The analyst firm set a price target for $10.00 expecting EKSO to rise to within 12 months (a possible 669.23% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Ekso Bionics Holdings (NASDAQ: EKSO) was provided by HC Wainwright & Co., and Ekso Bionics Holdings maintained their buy rating.
There is no last upgrade for Ekso Bionics Holdings.
There is no last downgrade for Ekso Bionics Holdings.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ekso Bionics Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ekso Bionics Holdings was filed on April 30, 2024 so you should expect the next rating to be made available sometime around April 30, 2025.
While ratings are subjective and will change, the latest Ekso Bionics Holdings (EKSO) rating was a maintained with a price target of $9.25 to $10.00. The current price Ekso Bionics Holdings (EKSO) is trading at is $1.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.